Mycenax Biotech Inc. (TPEX:4726)

Mycenax Biotech Revenue

Mycenax Biotech had revenue of 196.81M TWD in the quarter ending March 31, 2026, with 61.70% growth. This brings the company's revenue in the last twelve months to 815.34M, up 12.39% year-over-year. In the year 2025, Mycenax Biotech had annual revenue of 740.24M with 8.23% growth.

• Revenue (ttm): 815.34M
• Revenue Growth: +12.39%
• P/S Ratio: 6.90
• Revenue / Employee: 2.11M
• Employees: 387
• Market Cap: 5.63B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	740.24M	56.31M	8.23%
Dec 31, 2024	683.92M	31.30M	4.80%
Dec 31, 2023	652.62M	-79.66M	-10.88%
Dec 31, 2022	732.28M	-41.99M	-5.42%
Dec 31, 2021	774.27M	108.93M	16.37%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 27, 2026

Data Sources Report a data error